-
Dendreon Plunges on Restructuring News; Stock Downgraded
Tuesday, July 31, 2012 - 3:09pm | 408Read More...The share price of biotech firm Dendreon (NASDAQ: DNDN) plunged on Tuesday after the company released its second-quarter earnings results and announced a restructuring plan that will trim 600 jobs. In afternoon trading, Dendreon was down around 23 percent. The company hit a new 52-week low earlier...
-
Dendreon Surges 12% on Continued Speculation
Tuesday, July 24, 2012 - 10:43am | 167Read More...Shares of Dendreon (NASDAQ: DNDN) saw increased strength during Tuesday's early morning trading session as investors bid up shares on further speculation that the company may be in the works of selling itself. There were rumors spreading on Twitter that Celgene (NASDAQ: CELG) could be looking to...
-
ISI Group Comments on Dendreon's CEO Stepping Down
Wednesday, February 1, 2012 - 8:42am | 108Read More...ISI Group has published a research report on Dendreon (NYSE: DNDN) after the announcement that CEO Mitch Gold would be stepping down and replaced by John Johnson. In the report, ISI Group writes, "We believe the market will react well to this development and we look forward to understanding the...
-
Deutsche Bank Maintains Buy on Dendreon after CEO Steps Down
Wednesday, February 1, 2012 - 8:40am | 100Read More...Deutsche Bank has published a research report on Dendreon (NASDAQ: DNDN) after the announcement that CEO Mitch Gold is stepping down. In the report, Deutsche Bank writes, "New CEO John Johnson has history of M&A. Successfully sold ImClone to Eli Lilly & attempted to sell Savient. Our Take...
